Vaso Corporation (VASO)
| Market Cap | 30.35M |
| Revenue (ttm) | 89.11M |
| Net Income (ttm) | 2.59M |
| Shares Out | 175.95M |
| EPS (ttm) | 0.01 |
| PE Ratio | 11.71 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,400 |
| Average Volume | 80,296 |
| Open | 0.1601 |
| Previous Close | 0.1700 |
| Day's Range | 0.1601 - 0.1725 |
| 52-Week Range | 0.1050 - 0.2059 |
| Beta | 0.46 |
| RSI | 58.52 |
| Earnings Date | Mar 31, 2026 |
About Vaso Corporation
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. It operates in three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed healthcare software solutions, including diagnostic imaging applications; managed network infrastructure, such as routers, switches, and other equipment; managed network transport; and m... [Read more]
Financial Performance
In 2024, Vaso Corporation's revenue was $86.77 million, an increase of 7.09% compared to the previous year's $81.02 million. Earnings were $951,000, a decrease of -80.21%.
Financial StatementsNews
The Zacks Analyst Blog Highlights Eli Lilly, Shell, ICICI Bank, Frequency Electronics and Vaso
Eli Lilly anchors Zacks' latest Analyst Blog, with new research highlighting pharma growth drivers alongside global energy and banking insights.
Vaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCare
Vaso Corporation 137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 Investor Contact: Jonathan NewtonInvestor RelationsPhone: 516-997-4600 Email: jnewton@vasocorpora...
Vaso Stock Up Following Strong Q3 Earnings and Profit Turnaround
VASO reports a third-quarter 2025 profit turnaround with higher revenue, stronger margins and robust cash flow from subscriptions.
Vaso announces divestiture of VasoHealthcare for $0.8M
Vaso (VASO) sells VasoHealthcare IT to Nano-X Imaging for up to $0.8M, refocusing on core operations. Learn how this move impacts future investments.
Vaso Corporation Announces Divestiture of Subsidiary
Vaso Corporation 137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 Investor Contact: Jonathan NewtonInvestor RelationsPhone: 516-997-4600 Email: jnewton@vasocorpora...
VASO Posts Strong Q3 2025 Financial Results with Revenue and Income Growth
VASO Posts Strong Q3 2025 Financial Results with Revenue and Income Growth
Vaso Corporation Announces Financial Results for Third Quarter of 2025
PLAINVIEW, N.Y., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, profe...
The Zacks Analyst Blog Highlights Roche, Linde, Disney and Vaso
Zacks spotlights Roche, Linde, Disney, and Vaso as analysts weigh drug demand, gas contracts, global expansion, and IT-driven resilience.
Vaso Corporation Announces Financial Results for First Quarter of 2025
PLAINVIEW, N.Y., May 15, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, profes...
CORRECTION - Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2024
PLAINVIEW, N.Y., March 31, 2025 (GLOBE NEWSWIRE) -- Please note that, in a release issued under the same headline earlier today by Vaso Corporation (OTCQX: VASO), some figures in the written descripti...
Vaso Corporation Announces Executive Leadership Appointments & Names New Vice Chairman to the Board of Directors
PLAINVIEW, N.Y, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leader in human capital, information technology and MedTech, today announced new executive appointments to ...
Vaso Corporation CEO Reflects on a Year of Growth and Innovation in End-of-Year Letter Setting the Tone for a Promising 2025
Vaso Corporation 137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 NEWS RELEASE PLAINVIEW, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX:...
Vaso Corporation Announces Financial Results for Third Quarter 2024
PLAINVIEW, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading medtech company with a diversified business portfolio in network and healthcare IT services, profe...
Vaso announces termination of business combination with Achari Ventures Holdings Corp. I
Vaso Corporation (VASO) Wednesday announced that it has provided notice to SPAC Achari Ventures Holdings Corp. I to terminate the previously announced business combination.
Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I
PLAINVIEW, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO) today announced that it has provided notice to Achari Ventures Holdings Corp. I (“Achari”) to terminate the...
Vaso Corporation Announces Date Change for Its Stockholders Meeting
PLAINVIEW, N.Y., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO) today announced that at its special stockholders meeting on August 26, 2024, the meeting was adjourned withou...
Vaso Corporation Announces Financial Results for Second Quarter 2024
High deferred revenue and backlog setting stage for 2024 revenue and income growth PLAINVIEW, N.Y., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO) today reported its operati...
Vaso Corporation Announces the Effectiveness of the Achari Ventures Holdings Corp. I Registration Statement on Form S-4
A significant milestone for Vaso's Listing on NASDAQ Vaso Stockholders Meeting Scheduled for August 26, 2024 to Approve Business Combination with Achari PLAINVIEW, N.Y., Aug. 07, 2024 (GLOBE NEWSWIRE)...
Vaso Corporation Announces Financial Results for First Quarter 2024
PLAINVIEW, N.Y., May 15, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO) today reported its operating results for the three months ended March 31, 2024.
Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2023
PLAINVIEW, N.Y., April 01, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO) today announced its operating results for the three months and year ended December 31, 2023.
Vaso Corporation, a Diversified Medical Technology Company Currently Trading on the OTCQX Market, to List on Nasdaq via SPAC Merger
Business Combination with Achari Ventures Holdings Corp. I is Expected to Be Completed in First Quarter of 2024 Merger with Achari Ventures Holdings Corp. I (NASDAQ:AVHI) expected to improve capital m...
Vaso Corporation Announces Financial Results for Third Quarter 2023
Making it the sixth consecutive quarter of profitability PLAINVIEW, NY / ACCESSWIRE / November 14, 2023 / Vaso Corporation ("Vaso") (OTCQX:VASO) today reported its operating results for the three mont...
Vaso Corporation Announces Upgrade to OTCQX Best Market from OTCQB Venture Market
PLAINVIEW, NY / ACCESSWIRE / September 25, 2023 / Vaso Corporation ("Vaso") (OTCQB:VASO) today announced that its application to trade on the OTCQX Best Market has been approved by OTC Markets Group, ...
Vaso Corporation Announces Financial Results for Second Quarter 2023
Company reports continued growth in revenue and record profitability PLAINVIEW, NY / ACCESSWIRE / August 14, 2023 / Vaso Corporation ("Vaso") (OTCQB:VASO) today reported its operating results for the ...
Vaso Corporation Announces Financial Results for First Quarter 2023
Revenue and Profitability Continued to Improve Year-over-year PLAINVIEW, NY / ACCESSWIRE / May 15, 2023 / Vaso Corporation ("Vaso") (OTCQB:VASO) today reported its operating results for the three mont...